Stock Research for CDXS

CDXS
Current Price

$8.9750


Latest Update: 2018-02-20 16:00:00

High
$ 9.0500
Low
$ 8.9500
Close
$ 8.9500
Volume
15884
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

CDXS Stock Chart & Research Data

The CDXS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CDXS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CDXS Due diligence Resources & Stock Charts

The CDXS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CDXS Detailed Price Forecast - CNN Money CNN View CDXS Detailed Summary - Google Finance
Yahoo View CDXS Detailed Summary - Yahoo! Finance Zacks View CDXS Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View CDXS Trends & Analysis - Trade-Ideas Barrons View CDXS Major Holders - Barrons
NASDAQ View CDXS Call Transcripts - NASDAQ Seeking View CDXS Breaking News & Analysis - Seeking Alpha
Spotlight View CDXS Annual Report - CompanySpotlight.com OTC Report View CDXS OTC Short Report - OTCShortReport.com
TradeKing View CDXS Fundamentals - TradeKing Charts View CDXS SEC Filings - Bar Chart
WSJ View Historical Prices for CDXS - The WSJ Morningstar View Performance/Total Return for CDXS - Morningstar
MarketWatch View the Analyst Estimates for CDXS - MarketWatch CNBC View the Earnings History for CDXS - CNBC
StockMarketWatch View the CDXS Earnings - StockMarketWatch MacroAxis View CDXS Buy or Sell Recommendations - MacroAxis
Bullish View the CDXS Bullish Patterns - American Bulls Short Pains View CDXS Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View CDXS Stock Mentions - StockTwits PennyStocks View CDXS Stock Mentions - PennyStockTweets
Twitter View CDXS Stock Mentions - Twitter Invest Hub View CDXS Investment Forum News - Investor Hub
Yahoo View CDXS Stock Mentions - Yahoo! Message Board Seeking Alpha View CDXS Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for CDXS - SECform4.com Insider Cow View Insider Transactions for CDXS - Insider Cow
CNBC View CDXS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CDXS - OTC Markets
Yahoo View Insider Transactions for CDXS - Yahoo! Finance NASDAQ View Institutional Holdings for CDXS - NASDAQ


Stock Charts

FinViz View CDXS Stock Insight & Charts - FinViz.com StockCharts View CDXS Investment Charts - StockCharts.com
BarChart View CDXS Stock Overview & Charts - BarChart Trading View View CDXS User Generated Charts - Trading View


Latest Financial News for CDXS

Codexis Appoints Molecular Diagnostics Industry Veteran Shawn Clairmont to Lead High-Performance Enzymes Commercialization
Posted on Thursday February 15, 2018

REDWOOD CITY, Calif., Feb. 15, 2018-- Codexis, Inc., a leading protein engineering company, announces the appointment of Shawn Clairmont to the newly created position of Senior Director, Molecular Diagnostics. ...


Codexis to Present at the 25th International Molecular Medicine Tri-Conference
Posted on Monday February 12, 2018

REDWOOD CITY, Calif., Feb. 12, 2018-- Codexis, Inc., a leading protein engineering company, announces that John Nicols, President & CEO, will discuss the development of an improved DNA ligase for the molecular ...


3 Stocks Wall Street Hasn't Heard of Yet
Posted on Monday January 22, 2018

Investors haven't been paying enough attention to Franco Nevada, National Beverage, or Codexis.


Codexis, Inc. :CDXS-US: Earnings Analysis: Q3, 2017 By the Numbers : December 28, 2017
Posted on Thursday December 28, 2017

Categories: Yahoo FinanceGet free summary analysis Codexis, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Codexis, Inc. – Balchem Corporation, Pfizer Inc. and Royal Dutch Shell Plc Sponsored ADR Class A (BCPC-US, PFE-US and RDS.A-US) that have also reported for this period. Highlights Summary ... Read more (Read more...)


Codexis Appoints Molecular Diagnostics Industry Veteran Shawn Clairmont to ...
GlobeNewswire (press release) - Feb 15, 2018
REDWOOD CITY, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the appointment of Shawn Clairmont to the newly created position of Senior Director, Molecular Diagnostics.

Codexis Inc. (CDXS) Soars 6.25% on February 19
Equities.com - Feb 19, 2018
Codexis Inc. (CDXS) had a good day on the market for Monday February 19 as shares jumped 6.25% to close at $9.35. About 290,616 shares traded hands on 1,940 trades for the day, compared with an average daily volume of 249,347 shares out of a total ...

Codexis to Present at the 25th International Molecular Medicine Tri-Conference
GlobeNewswire (press release) - Feb 12, 2018
REDWOOD CITY, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that John Nicols, President & CEO, will discuss the development of an improved DNA ligase for the molecular ...

Vivo Capital, Llc is the third biggest owner of Codexis, Inc. (CDXS)
Post Analyst - 15 hours ago
Codexis, Inc. (NASDAQ:CDXS) enjoyed a 159.72% run-up in share price since hitting record low of $3.60. The stock managed 6.25% rise and now stands at $9.35 as of 02/16/2018.
$0.06 EPS Expected for Codexis, Inc. (CDXS) - BZ Weekly

Enter a stock symbol to view the stock details.